Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04363801
Title A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer (DisTinGuish)
Acronym DisTinGuish
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Leap Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | DEU


No variant requirements are available.